Johnson & Johnson plans to increase U.S. investments by 25% to over $55 billion in the next four years. The Trump administration’s threat of drug import…
Browsing: #PHARMACEUTICALS
AstraZeneca will acquire biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec’s “Engineered NanoBody Lentiviral (ENaBL) platform can genetically modify immune cells directly inside the body,…
Eli Lilly (LLY.N) announced on Thursday that it has sued the federal Health Resources and Services Administration (HRSA). The company claims that HRSA is blocking its…
Activist investor Starboard Value has invested roughly $1 billion in Pfizer. The firm wants the American pharmaceutical company to make changes to improve its performance, according…
GSK, a British pharmaceutical corporation, sold institutional investors its remaining ownership in Haleon, a consumer healthcare company, for 1.25 billion pounds ($1.52 billion). With the sale, GSK will…
On Monday, the U.S. Food and Drug Administration (FDA) announced the full approval of Pfizer’s medication for treating individuals with cervical cancer, whose disease has advanced…
On Thursday, Moderna announced it had postponed plans to develop a vaccine manufacturing facility in Kenya. This decision came as demand for COVID-19 vaccines dropped following…
Boehringer Ingelheim, a German drugmaker, expressed its aspiration to launch survodutide, a drug candidate co-developed with Zealand Pharma (ZELA.CO), with the potential to treat obesity and…
Pfizer (PFE.N) has agreed to pay $93 million to settle antitrust claims filed by wholesale drug distributors. The distributors accused Pfizer of conspiring with India’s Ranbaxy…
Germany’s leading pharmaceutical company Boehringer Ingelheim released a statement stating it would conduct three late-stage studies for its obesity drug candidate this Thursday after a result…